. Management Impact of Imaging Brain Vesicular Monoamine Transporter type-2 (VMAT2) in Clinically Uncertain Parkinsonian Syndrome (CUPS) with (18)F-AV133 and PET. J Nucl Med. 2017 May 10; PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.